1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
Genmab - ADR XNAS: GMAB

Genmab - ADR Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...

Read More
25.89 1.02 (4.10%)
50.17% Gain from 52W Low
2.1M
XNAS Volume

XNAS 02 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
45.2 / 100
Momentum Score
Technically Moderately Bullish
65.4 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
31
1Yr Price target upside is 18%
8 analysts

24

S

2

W

1

O

2

T

SWOT Analysis

Genmab - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..